SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis
详细信息 查看全文
- 作者：Carmen Gómez-Vaquero (7)
Alfonso Corrales (8)
Andrea Zacarías (7)
Javier Rueda-Gotor (8)
Ricardo Blanco (8)
Carlos González-Juanatey (9)
Javier Llorca (10) (11)
Miguel A González-Gay (8) - 刊名：Arthritis Research & Therapy
- 出版年：2013
- 出版时间：August 2013
- 年：2013
- 卷：15
- 期：4
- 全文大小：182 KB
- 参考文献：1. Avi?a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D: Risk of CV mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. / Arthritis Rheum 2008, 59:1690-697. CrossRef
2. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. / Semin Arthritis Rheum 2005, 35:8-7. CrossRef
3. Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA: CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. / Arthritis Res Ther 2011, 13:R133. CrossRef
4. Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, Reddi K, Stanwix AE: Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. / J Rheumatol 2005, 32:435-42.
5. Sattar N, McCarey DW, Capell H, McInnes IB: Explaining how "high-grade" msystemic inflammation accelerates vascular risk in rheumatoid arthritis. / Circulation 2003, 108:2957-963. CrossRef
6. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pi?eiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J: HLA-DRB1 and persistent chronic inflammation contribute to CV events and CV mortality in patients with rheumatoid arthritis. / Arthritis Rheum 2007, 57:125-32. CrossRef
7. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ: Baseline levels of C-reactive protein and prediction of death from CV disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. / Arthritis Rheum 2005, 52:2293-299. CrossRef
8. Jacobsson LT, Turesson C, Hanson RL, Pillemer S, Sievers ML, Pettitt DJ, Bennett PH, Knowler WC: Joint swelling as a predictor of death from CV disease in a population study of Pima Indians. / Arthritis Rheum 2001, 44:1170-176. CrossRef
9. W?llberg-Jonsson S, Johansson H, Ohman ML, Rantap??-Dahlqvist S: Extent of inflammation predicts CV disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. / J Rheumatol 1999, 26:2562-571.
10. Marrugat J, Elosúa R, Martí H: Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005. / Rev Esp Cardiol 2002, 55:337-46. CrossRef
11. Sans S, Kesteloot H, Kromhout D: The burden of CV diseases mortality in Europe. Task force of the European Society of Cardiology on CV Mortality and Morbidity Statistics in Europe. / Eur Heart J 1997, 18:1231-248. CrossRef
12. Conroy RM, Py?r?l? K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Nj?lstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. / Eur Heart J 2003, 24:987-003. CrossRef
13. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW: Concept and usefulness of CV risk profiles. / Am Heart J 2004, 148:16-6. CrossRef
14. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB: An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. / J Epidemiol Community Health 2003, 57:634-38. CrossRef
15. D'Agostino RB, Grundy S, Sullivan LM, Wilson P for The CHD Risk Prediction Group: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. / JAMA 2001, 286:180-87. CrossRef
16. Ramos R, Solanas P, Cordón F, Rohlfs I, Elosua R, Sala J, Masiá R, Faixedas MT, Marrugat J: Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions. / Med Clin (Barc) 2003, 121:521-26.
17. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badia J, D'Agostino RB, VERIFICA Investigators: Validity of an adaptation of the Framingham CV risk function: the VERIFICA study. / J Epidemiol Community Health 2007, 61:40-7. CrossRef
18. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT: EULAR evidence-based recommendations for CV risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. / Ann Rheum Dis 2010, 69:325-31. CrossRef
19. Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Végh E, Shoenfeld Y, McInnes I, Szekanecz Z: Validated methods for assessment of subclinical atherosclerosis in rheumatology. / Nat Rev Rheumatol 2012, 8:224-34. CrossRef
20. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J: Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. / Semin Arthritis Rheum 2008, 38:67-0. CrossRef
21. Belcaro G, Nicolaides AN, Ramaswami G, Cesarone MR, De Sanctis M, Incandela L, Ferrari P, Geroulakos G, Barsotti A, Griffin M, Dhanjil S, Sabetai M, Bucci M, Martines G: Carotid and femoral ultrasound morphology screening and CV events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study (1)). / Atherosclerosis 2001, 156:379-87. CrossRef
22. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM: Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. / J Am Coll Cardiol 2010, 55:1600-607. CrossRef
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, / et al.: 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). / J Hypertens 2007, 25:1105-187. CrossRef
24. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-010 and 2010-012 Committees: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). / Eur Heart J 2011, 32:1769-818. CrossRef
25. van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT: Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. / Semin Arthritis Rheum 2011, 40:389-97. CrossRef
26. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. / Medicine (Baltimore) 2003, 82:407-13. CrossRef
27. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA: Carotid intima-media thickness predicts the development of CV events in patients with rheumatoid arthritis. / Semin Arthritis Rheum 2009, 38:366-71. CrossRef
28. Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rincón I: Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. / Arthritis Rheum 2011, 63:1211-220. CrossRef
29. Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA: Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. / Ann Rheum Dis 2013, in press.
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. / Arthritis Rheum 1988, 31:315-24. CrossRef
31. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, / et al.: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. / Ann Rheum Dis 2010, 69:1580-588. CrossRef
32. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M: Mannheim carotid intima-media thickness consensus (2004-006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. / Cerebrovasc Dis 2007, 23:75-0. CrossRef
33. Baena Díez JM, del Val Garcia JL, Héctor Salas Gaetgens L, Sánchez Pérez R, Altes Vaques E, Deixens Martínez B, Amatller Corominas M, Katia Nú?ez Casillas D: Comparison of the SCORE and REGICOR models for calculating CV risk in CV disease-free individuals at a healthcare center in Barcelona, Spain. / Rev Esp Salud Publica 2005, 79:453-64. CrossRef
34. Buitrago F, Ca?ón-Barroso L, Díaz-Herrera N, Cruces-Muro E, Escobar-Fernández M, Serrano-Arias JM: Comparison of the REGICOR and SCORE function charts for classifying CV risk and for selecting patients for hypolipidemic or antihypertensive treatment. / Rev Esp Cardiol 2007, 60:139-47. CrossRef
35. Gil-Guillén V, Orozco-Beltrán D, Maiques-Galán A, Aznar-Vicente J, Navarro J, Cea-Calvo L, Quirce-Andrés F, Redón J, Merino-Sánchez J: Agreement between REGICOR and SCORE scales in identifying high CV risk in the Spanish population. / Rev Esp Cardiol 2007, 60:1042-050. CrossRef
36. Comín E, Solanas P, Cabezas C, Subirana I, Ramos R, Gené-Badía J, Cordón F, Grau M, Cabré-Vila JJ, Marrugat J: Estimating CV risk in Spain using different algorithms. / Rev Esp Cardiol 2007, 60:693-02. CrossRef
37. Buitrago Ramírez F, Ca?ón Barroso L, Díaz Herrera N, Cruces Muro E, Bravo Simón B, Pérez Sánchez I: Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the CV risk in an urban population after 10 years of follow-up. / Med Clin (Barc) 2006, 127:368-73. CrossRef
38. del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of CV events in a RA cohort not explained by traditional cardiac risk factors. / Arthritis Rheum 2001, 44:2737-745. CrossRef
39. Crowson CS, Gabriel SE: Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. / Ann Rheum Dis 2011, 70:719-21. CrossRef - 作者单位：Carmen Gómez-Vaquero (7)
Alfonso Corrales (8)
Andrea Zacarías (7)
Javier Rueda-Gotor (8)
Ricardo Blanco (8)
Carlos González-Juanatey (9)
Javier Llorca (10) (11)
Miguel A González-Gay (8)
7. Rheumatology Division, Hospital Universitari de Bellvitge-IDIBELL, L’Hopitalet, Barcelona, Spain
8. Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Avenida de Valdecilla, s/n, E-39008, Santander, 39008, Spain
9. Cardiology Division of, Hospital Lucus Augusti, Lugo, Spain
10. Division of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, Santander, Spain
11. CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain - ISSN：1478-6354
文摘
Introduction Our objective was to determine which one of the two function charts available in Spain to calculate cardiovascular (CV) risk, Systematic COronary Risk Evaluation (SCORE) or Framingham-REgistre GIroní del COR (REGICOR), should be used in patients with rheumatoid arthritis (RA). Methods A series of RA patients seen over a one-year period without history of CV events were assessed. SCORE, REGICOR, modified (m)SCORE and mREGICOR according to the European League Against Rheumatism (EULAR) recommendations were applied. Carotid ultrasonography (US) was performed. Carotid intima-media thickness (cIMT) > 0.90 mm and/or carotid plaques were used as the gold standard test for severe subclinical atherosclerosis and high CV risk (US+). The area under the receiver operating curves (AUC) for the predicted risk for mSCORE and mREGICOR were calculated according to the presence of severe carotid US findings (US+). Results We included 370 patients (80% women; mean age 58.9 ± 13.7 years); 36% had disease duration of 10 years or more; rheumatoid factor (RF) and/or anticyclic citrullinated peptide (anti-CCP) were positive in 68%; and 17% had extra-articular manifestations. The EULAR multiplier factor was used in 122 (33%) of the patients. The mSCORE was 2.16 ± 2.49% and the mREGICOR 4.36 ± 3.46%. Regarding US results, 196 (53%) patients were US+. The AUC mSCORE was 0.798 (CI 95%: 0.752 to 0.844) and AUC mREGICOR 0.741 (95% CI; 0.691 to 0.792). However, mSCORE and mREGICOR failed to identify 88% and 91% of US+ patients. More than 50% of patients with mSCORE ?% or mREGICOR >1% were US+. Conclusions Neither of these two function charts was useful in estimating CV risk in Spanish RA patients.